Constitutive CCND1/CDK2 activity conferred resistance to TGF-β induced growth arrest in MMTVD1-K2 driven mouse mammary tumor cells, and CCND1 is a downstream effector of RAS [22], [23]. This evidence concerns the gene CCND1 and breast cancer.